Novartis AG (NOVN.SW)

CHF 88.04

(-0.77%)

Long Term Debt Summary of Novartis AG

  • Novartis AG's latest annual long term debt in 2023 was 20.03 Billion USD , down -8.02% from previous year.
  • Novartis AG's latest quarterly long term debt in 2024 Q3 was 23.75 Billion USD , up 20.79% from previous quarter.
  • Novartis AG reported annual long term debt of 21.78 Billion USD in 2022, down -11.18% from previous year.
  • Novartis AG reported annual long term debt of 24.52 Billion USD in 2021, down -12.35% from previous year.
  • Novartis AG reported quarterly long term debt of 23.75 Billion USD for 2024 Q3, up 20.79% from previous quarter.
  • Novartis AG reported quarterly long term debt of 18.72 Billion USD for 2024 Q1, down -6.75% from previous quarter.

Annual Long Term Debt Chart of Novartis AG (2023 - 1998)

Historical Annual Long Term Debt of Novartis AG (2023 - 1998)

Year Long Term Debt Long Term Debt Growth
2023 20.03 Billion USD -8.02%
2022 21.78 Billion USD -11.18%
2021 24.52 Billion USD -12.35%
2020 27.97 Billion USD 26.85%
2019 22.05 Billion USD -1.84%
2018 22.47 Billion USD -3.25%
2017 23.22 Billion USD 29.76%
2016 17.89 Billion USD 9.62%
2015 16.32 Billion USD 18.32%
2014 13.79 Billion USD 22.75%
2013 11.24 Billion USD -18.42%
2012 13.78 Billion USD -0.53%
2011 13.85 Billion USD -3.52%
2010 14.36 Billion USD 65.53%
2009 8.67 Billion USD 298.3%
2008 2.17 Billion USD 221.71%
2007 677 Million USD 3.2%
2006 656 Million USD -50.27%
2005 1.31 Billion USD -51.79%
2004 2.73 Billion USD -14.26%
2003 3.19 Billion USD 16.63%
2002 2.73 Billion USD 81.91%
2001 1.5 Billion USD 8.05%
2000 1.39 Billion USD -9.43%
1999 1.53 Billion USD -25.51%
1998 2.06 Billion USD 0.0%

Peer Long Term Debt Comparison of Novartis AG

Name Long Term Debt Long Term Debt Difference
Roche Holding AG 24.8 Billion CHF 19.247%
Roche Holding AG 24.8 Billion CHF 19.247%